Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update

• click to rate

  Posted by Two Blokes May 13 - Filed in Stock - 9 views
  
  Company Seeking Conditional Approval from European Medicines Agency (EMA) for Iopofosine I 131 in Waldenstrom Macroglobulinemia based upon CLOVER WaM Phase 2 Study Data